Onset of action of the beta 3-adrenoceptor agonist, mirabegron, in Phase II and III clinical trials in patients with overactive bladder
Christopher R. Chapple*, Victor W. Nitti, Vik Khullar, Jean Jacques Wyndaele, Sender Herschorn, Philip van Kerrebroeck, Mary Beth Blauwet, Emad Siddiqui
Research output: Contribution to journal › Article › Academic › peer-review
Fingerprint
Dive into the research topics of 'Onset of action of the beta 3-adrenoceptor agonist, mirabegron, in Phase II and III clinical trials in patients with overactive bladder'. Together they form a unique fingerprint.